Image

fMRI and Opioid Abstinence

fMRI and Opioid Abstinence

Recruiting
18-50 years
All
Phase N/A

Powered by AI

Overview

This project examines functional connectivity patterns associated with subsequent relapse to illicit opioids during treatment for OUD.

Eligibility

Inclusion Criteria:

  • recent initiation of methadone or buprenorphine at APT Foundation within the last year (i.e., period of time during which treatment drop-out and risk for relapse is highest);
  • eligibility for MRI scanning;
  • ability to commit to study visits.

Exclusion Criteria:

  • current acute psychosis, mania, or suicidal ideation with intent, as assessed during screening with the SCID-5;
  • current intoxication or acute withdrawal at time of study visit sufficient to prevent participation based on: behavioral observation, breathalyzer, and SOWS assessment;
  • severe cognitive impairment as determined via trained clinical research staff through consent process and during consent quiz or as indicated by a PROMIS Cognitive Function tscore <30 (i.e., severe impairment)
  • past or present history of intellectual disability, developmental disorder, or neurological disease;
  • head trauma with loss of consciousness >30 min;
  • organ dysfunction or any unstable or untreated medical conditions that may interfere with study participation.

Study details
    Drug Use Disorder
    Opioid Dependence
    Opioid-Related Disorders
    Opioid Use
    Opioid Abuse

NCT06651333

Yale University

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.